OPKO Health Inc OPK

Healthcare Medical Care

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company focuses on leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. Its segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, Rayaldee product sales and its pharmaceutical research and development. The diagnostics segment primarily consists of point-of-care operations. Its pharmaceutical business features Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage three or four chronic kidney disease (CKD) and vitamin D insufficiency, and Somatrogon (hGH-CTP), a once-weekly human growth hormone injection. Its NGENLA (somatrogon-ghla), is a once-weekly, human growth hormone analog indicated for treatment of pediatric patients aged three years and older.

NDAQ:OPK - Post by User

OPKO Health Inc > still holding this stock

Bullboard Posts

Next >>

Comment by TheSeedon Oct 10, 2020 8:50pm

154 Views

Post# 31701827

RE:RE:still holding this stock

Brought here by referral by rvr-trading.com. You should check it out. 17 bucks a month and the calls are fire. I've doubled my money in just 2 days. Definitely worth the cheddar. Be ready, this is gonna fly this week.

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security